AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval. In a recent phase III trial , the radiotracer was shown to be safe and effective for identifying small lesions, which could allow for earlier diagnosis of the disease.

Pharmaceutical 59

Pharmaceutical Disease Diagnostic IT 59

AuntMinnie

JULY 31, 2024

The company’s Pharmaceutical Diagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year.

Healthcare 52

Healthcare Healthcare Pharmaceutical Ultrasound 52

Imaging Technology

OCTOBER 11, 2023

based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP). milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based

Healthcare 105

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 105

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 57

Pharmaceutical Diagnose 57

Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

MRI Network

MARCH 25, 2024

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Pharmaceutical 59

Pharmaceutical Quality and Compliance Clinic Diagnostic 59

AuntMinnie

MARCH 5, 2024

Telix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million. Under the agreement, Telix will take on ARTMS’ cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultrapure rare metals such as zinc-68, which is irradiated to produce gallium-68.

Pharmaceutical 52

Pharmaceutical Diagnostic Imaging Diagnostic Imaging 52

Imaging Technology

JULY 25, 2024

Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

AuntMinnie

SEPTEMBER 22, 2024

Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced. RLS Radiopharmacies is the third-largest radiopharmacy network in the U.S. said Telix Managing Director and Group Chief Executive Officer Christian Behrenbruch, MD, in a news release.

Radiopharmaceuticals 52

Radiopharmaceuticals Pharmaceutical Diagnostic IT 52

Imaging Technology

OCTOBER 2, 2024

2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. In a production setting, pharmaceutical companies can reduce AI development time from weeks to hours—allowing therapies to reach patients much sooner.

Pharmaceutical 52

Pharmaceutical Patient Care Diagnose Imaging 52

Imaging Technology

NOVEMBER 2, 2023

After regional regulatory approvals, GE HealthCare plans to commercialize the models for use both in pharmaceutical drug development and for clinical decision support. These results are a promising development in the journey towards precision care, selecting treatment pathways based on the individual patient’s likely response.

Healthcare 59

Healthcare Healthcare Pharmaceutical Clinic 59

Imaging Technology

APRIL 24, 2023

In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Government 98

Imaging Technology

MAY 25, 2023

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S.,

Clinic 94

Clinic Healthcare Healthcare Imaging 94

Imaging Technology

FEBRUARY 12, 2024

Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. Reference: 1. NHS England (2017).

Pharmaceutical 105

Pharmaceutical Clinic Diagnostic IT 105

Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 105

Healthcare Healthcare Radiation Oncology Radiation 105

Imaging Technology

JULY 25, 2024

Sarcopenia is an inevitable symptom of aging, and yet there are no pharmaceutical interventions to prevent or address the issue. Muscle atrophy is a leading contributor to falls, fractures, hospitalization, and comorbidities, accounting for more than $40 billion in annual health care costs in the United States alone.

MRI 104

MRI Pharmaceutical Clinic Disease 104

Imaging Technology

NOVEMBER 20, 2023

In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. milla1cf Mon, 11/20/2023 - 12:27 November 20, 2023 — InMed.AI (InMed Prognostics Inc.), a pioneer in AI -driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749)

Pharmaceutical 104

Pharmaceutical Medical Device Disease Healthcare 104

Imaging Technology

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc.,

Interventional Radiology 105

Interventional Radiology Clinic Healthcare Healthcare 105

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

Imaging Technology

JANUARY 5, 2024

The new agreement also provides Curadh access to NorthStar’s integrated radiopharmaceutical development and manufacturing organization to support development and commercialization of future radiopharmaceutical diagnostic and therapeutic agents. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

JUNE 14, 2024

The recent FDA approval of Madrigal Pharmaceuticals' Rezdiffra (resmetirom) medication marks a significant milestone in the adoption of medical imaging for identifying and monitoring patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe progression, metabolic dysfunction-associated steatohepatitis (MASH). (..)

Imaging 52

Imaging Imaging Modalities Disease Medical Imaging 52

MRI Network

JANUARY 8, 2024

According to Today’s Medical Developments , the highest-performing medical devices in terms of sales are: In vitro diagnostic tools Cardiology devices Diagnostic imaging tools Other top-selling device categories include ophthalmic and dental, while the fastest-growing segment is devices related to neurology.

Medical Device 59

Medical Device Medical Pharmaceutical Healthcare 59

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

SEPTEMBER 7, 2023

Paige reports that it has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Notably, Paige is the first company to receive FDA approval for a clinical AI application in digital pathology.

Imaging 52

Imaging Pharmaceutical Hospital Clinic 52

Imaging Technology

JULY 25, 2023

ii More information: www.bracco.com VUEWAY injection is now available to order from Bracco Diagnostics Inc. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. Manufactured for Bracco Diagnostics Inc. NJ: Bracco Diagnostics Inc.;

MRI 98

MRI Magnetic Resonance Imaging Imaging Diagnostic 98

Imaging Technology

JUNE 15, 2023

Dr. Guy Lloyd , a cardiologist and specialist in diagnostic imaging who participated in the study, highlights the importance of healthcare leaders preparing for the changes of tomorrow, “AI is going to fundamentally change the way people work,” he predicts.

Healthcare 98

Healthcare Healthcare Clinic Pharmaceutical 98

AuntMinnie

APRIL 22, 2024

For CT and MRI procedures where injected contrast media is ordered, ".

Radiology Technologist 105

Radiology Technologist Medicare Basic Life Support Radiologist 105

Global Radiology CME

JULY 31, 2021

Echocardiography (Transesophageal > Transthoracic) is the diagnostic test of choice followed by cardiac MRI and CT scans to help better visualize the intracardiac mass for preoperative planning [2,3]. Cardiac myxoma as a mimic: a diagnostic challenge. Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int. Am J Emerg Med.

Global Radiology 52

Global Radiology Education MRI Pharmaceutical 52

AuntMinnie

AUGUST 5, 2024

Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. Diagnostic and Interventional Radiology , December 2006, Vol. In a worst-case scenario, gadolinium-based contrast agents could wind up in the same unenviable position as other pharmaceuticals. "I Giles, U.K.

Disease 116

Disease MRI Radiologist IT 116

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. RadioGenix Systems have generated almost two million doses of Tc-99m for patients’ diagnostic imaging studies to date, with utilization continuing to steadily increase. Our track record of success includes our program to supply U.S.-produced, Additional n.c.a.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JUNE 21, 2023

milla1cf Wed, 06/21/2023 - 19:47 June 21, 2023 — Fresenius Kabi , a leading provider of injectable medicines, announced today it has launched the diagnostic pharmaceutical agent, Sincalide for Injection, an authorized generic for Bracco Diagnostics Inc. ’s s Kinevac (Sincalide for Injection) product.

IT 98

IT Pharmaceutical Radiology X-ray 98

Imaging Technology

JULY 24, 2024

Not for use in diagnostic procedures. “We The company noted it recently released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows. Concentriq AP is for research use only.

DICOM 115

DICOM Pharmaceutical Diagnostic Disease 115

Imaging Technology

JULY 3, 2024

The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. The same spatial mapping will also enable Nucleai’s applications to serve as companion diagnostics that match patients to the most effective treatment.

Pharmaceutical 59

Pharmaceutical Diagnostic Patient Care Clinic 59

Future Teleradiology

APRIL 3, 2020

Also, the new online pharmaceutical retail industry is gradually penetrating the market. Connecting the dots, MRI teleradiology reporting is going to be a viable option for healthcare centers, hospitals and diagnostic centers in tier 2, tier 3 cities and rural areas.

Teleradiology 52

Teleradiology MRI Government Hospital 52

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

MARCH 21, 2024

christine.book Thu, 03/21/2024 - 10:34 March 21, 2024 — Diagnostic imaging provider US Radiology Specialists has announced that Lee Cooper will become its new Chief Executive Officer (CEO), and that current board member Molly Joseph will become its next Board Chair. Cooper and Joseph will succeed John Perkins , U.S.

Healthcare 103

Healthcare Healthcare Radiology Government 103

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 52